Sign In
Buy LFMD
$4.56
-0.130 (-2.77%)
At Close: Jun 03, 2026
NEW YORK, May 18, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. f/k/a Conversion Labs, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) a
LifeMD™ Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06:00pm, Monday, 17'th May 2021
NEW YORK, May 17, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that the Compensation Committee of the Comp
LifeMD (LFMD) Stock: Over 24% Increase Explanation
01:02pm, Friday, 14'th May 2021
The stock price of LifeMD Inc (NASDAQ: LFMD) increased by over 24% during intraday trading. This is why it happened.
LifeMD, Inc. (LFMD) CEO Justin Schreiber on Q1 2021 Results - Earnings Call Transcript
10:44pm, Thursday, 13'th May 2021
LifeMD, Inc. (LFMD) CEO Justin Schreiber on Q1 2021 Results - Earnings Call Transcript
LifeMD, Inc. (LFMD) Reports Q1 Loss, Lags Revenue Estimates
08:26pm, Thursday, 13'th May 2021
LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 13.64% and -0.12%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against LifeMD, Inc. (LFMD)
11:12am, Thursday, 13'th May 2021
LOS ANGELES, May 13, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 15, 2021 deadline to file a lead plaintiff motion in the class action filed on
Do Options Traders Know Something About LifeMD (LFMD) Stock We Don't?
09:46am, Wednesday, 12'th May 2021
Investors need to pay close attention to LifeMD (LFMD) stock based on the movements in the options market lately.
NEW YORK, May 11, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. f/k/a Conversion Labs, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) a
SAN DIEGO & NEW YORK--(BUSINESS WIRE)---- $LFMD #ClassAction--Shareholder rights law firm Robbins LLP reminds investors that a purchaser of LifeMD f/k/a Conversion Labs, Inc. (NASDAQ: LFMD) filed a cl
Pomerantz Law Firm Announces the Filing of a Class Action Against LifeMD, Inc. f/k/a Conversion Labs, Inc. and Certain Officers - LFMD
11:00pm, Wednesday, 05'th May 2021
NEW YORK, May 5, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. f/k/a Conversion Labs, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) an
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of LifeMD, Inc. (LFMD) Investors
11:00am, Tuesday, 04'th May 2021
Los Angeles, May 4, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired L
New York, New York--(Newsfile Corp. - April 30, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or the "Company"
NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company�
NEW YORK, April 23, 2021 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the S
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against LifeMD, Inc. (LFMD)
11:00am, Friday, 23'rd Apr 2021
LOS ANGELES--(BUSINESS WIRE)---- $LFMD #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 15, 2021 deadline to file a lead plaintiff motion in the class actio
